A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.

A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.

Low-dose aspirin (LDA) frequently causes small bowel injury. While some drugs have been reported to be effective in treating LDA-induced small intestinal damage, most studies did not exclude patients with mild damage thought to be clinically insignificant.We conducted a multicenter, randomized, doub...

Full description

Bibliographic Details
Main Authors: Toshio Watanabe, Toshihisa Takeuchi, Osamu Handa, Yasuhisa Sakata, Tetsuya Tanigawa, Masatsugu Shiba, Yuji Naito, Kazuhide Higuchi, Kazuma Fujimoto, Toshikazu Yoshikawa, Tetsuo Arakawa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4398323?pdf=render

Internet

http://europepmc.org/articles/PMC4398323?pdf=render

Similar Items